According to statistics, the average survival of patients with anaplastic astrocytoma (overall) is approximately five years [9]; however, this applies mainly to patients with IDH-mutant tumors, younger individuals, and those in good general condition. The gene discussed is IDH2; the disease is anaplastic astrocytoma.